Probiotic interventions to reduce antepartum Group B streptococcus colonization: A systematic review and meta-analysis.

[1]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[2]  L. Hanson,et al.  Laboratory Analysis Techniques for the Perinatal Microbiome , 2020, The Journal of perinatal & neonatal nursing.

[3]  C. Foschi,et al.  In-vitro effect of vaginal lactobacilli against group B Streptococcus. , 2019, Microbial pathogenesis.

[4]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[5]  Mary Sharpe,et al.  Effectiveness of oral intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on Group B Streptococcus colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  Acog Committee Opinion.  Prevention of Group B Streptococcal Early-Onset Disease in Newborns , 2019, Pediatrics.

[7]  Lakshmi Rajagopal,et al.  The Double Life of Group B Streptococcus: Asymptomatic Colonizer and Potent Pathogen. , 2019, Journal of molecular biology.

[8]  T. Raudaskoski,et al.  The effect of screening‐to‐labor interval on the sensitivity of late‐pregnancy culture in the prediction of group B streptococcus colonization at labor: A prospective multicenter cohort study , 2019, Acta obstetricia et gynecologica Scandinavica.

[9]  J. M. Rodríguez,et al.  Rectal and Vaginal Eradication of Streptococcus agalactiae (GBS) in Pregnant Women by Using Lactobacillus salivarius CECT 9145, A Target-specific Probiotic Strain , 2019, Nutrients.

[10]  W. Schaffner,et al.  Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance , 2019, JAMA pediatrics.

[11]  D. Ferris,et al.  A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Beck,et al.  Prevalence of group B Streptococcal colonization among pregnant women and neonates in a tertiary hospital in India , 2017, Journal of the Turkish German Gynecological Association.

[13]  S. Madhi,et al.  Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Madhi,et al.  Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  P. Gajer,et al.  Group B Streptococcus and the Vaginal Microbiota , 2017, The Journal of infectious diseases.

[16]  K. O’Brien,et al.  Prevalence and Risk Factors for Infections in a Pregnant Adolescent Population. , 2017, Journal of pediatric and adolescent gynecology.

[17]  F. Pierro,et al.  Positive clinical outcomes derived from using a proprietary mixture of selected strains during pregnancy , 2017 .

[18]  P. Smith,et al.  Risk factors for Group B streptococcal disease in neonates of mothers with negative antenatal testing , 2016, Journal of Perinatology.

[19]  Wei-Chun Chang,et al.  Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial. , 2016, Taiwanese journal of obstetrics & gynecology.

[20]  P. Ravaud,et al.  Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review , 2016, BMC Medical Research Methodology.

[21]  G. Reid,et al.  The case in favour of probiotics before, during and after pregnancy: insights from the first 1,500 days. , 2016, Beneficial microbes.

[22]  K. Doran,et al.  Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization , 2015, Infection and Immunity.

[23]  C. Menéndez,et al.  Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine. , 2015, The Journal of antimicrobial chemotherapy.

[24]  T. Gosiewski,et al.  Dynamics of colonization with group B streptococci in relation to normal flora in women during subsequent trimesters of pregnancy. , 2014, The new microbiologica.

[25]  S. Fijan.  Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature , 2014, International journal of environmental research and public health.

[26]  L. Hanson,et al.  Feasibility of oral prenatal probiotics against maternal group B Streptococcus vaginal and rectal colonization. , 2014, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[27]  G. Gherardi,et al.  Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. , 2013, The Journal of pediatrics.

[28]  P. Heath,et al.  An overview of global GBS epidemiology. , 2013, Vaccine.

[29]  C. D. de Groot,et al.  Implementation of a cost-effective strategy to prevent neonatal early-onset group B haemolytic streptococcus disease in the Netherlands , 2013, BMC Pregnancy and Childbirth.

[30]  G. Reid,et al.  The Rationale for Probiotics Improving Reproductive Health and Pregnancy Outcome , 2013, American journal of reproductive immunology.

[31]  Urs Brugger,et al.  Automated Counting of Bacterial Colony Forming Units on Agar Plates , 2012, PloS one.

[32]  I. Mitov,et al.  Coadministration of probiotics with antibiotics: why, when and for how long? , 2012, Expert review of anti-infective therapy.

[33]  M. Williamson,et al.  The impact of oral probiotics on vaginal Group B Streptococcal colonisation rates in pregnant women: A pilot randomised control study. , 2011, Women and birth : journal of the Australian College of Midwives.

[34]  Noel A. Card.  Applied Meta-Analysis for Social Science Research , 2011 .

[35]  S. Shiboski,et al.  Phase 2a Study Assessing Colonization Efficiency, Safety, and Acceptability of Lactobacillus crispatus CTV-05 in Women With Bacterial Vaginosis , 2010, Sexually transmitted diseases.

[36]  C. Påhlson,et al.  Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. , 2010, Microbes and infection.

[37]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[38]  M. N. Moghaddam.  Recto-vaginal colonization of group B streptococcus in pregnant women referred to a hospital in Iran and its effect on lactobacillus normal flora. , 2010 .

[39]  G. Reid,et al.  Targeting the vaginal microbiota with probiotics as a means to counteract infections , 2009, Current opinion in clinical nutrition and metabolic care.

[40]  W. Schaffner,et al.  Evaluation of universal antenatal screening for group B streptococcus. , 2009, The New England journal of medicine.

[41]  L. Meyn,et al.  Rectal colonization by group B Streptococcus as a predictor of vaginal colonization. , 2009, American journal of obstetrics and gynecology.

[42]  R. Greene,et al.  Self-collected versus health professional-collected genital swabs to identify the prevalence of group B streptococcus: a comparison of patient preference and efficacy. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[43]  B. Gillespie,et al.  Risk factors for group B streptococcal colonization: potential for different transmission systems by capsular type. , 2007, Annals of epidemiology.

[44]  M. Bracken,et al.  Duration of Intrapartum Prophylaxis for Neonatal Group B Streptococcal Disease: A Systematic Review , 2006, Obstetrics and gynecology.

[45]  M. Nader-Macías,et al.  Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells , 2006, Letters in applied microbiology.

[46]  U. Forsgren-Brusk,et al.  Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. , 2006, Acta obstetricia et gynecologica Scandinavica.

[47]  K. Chan,et al.  Evaluation of the sensitivity of a rapid polymerase chain reaction for detection of group B streptococcus , 2006, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[48]  J. Kahn,et al.  Risk Factors for Group B Streptococcal Genitourinary Tract Colonization in Pregnant Women , 2005, Obstetrics and gynecology.

[49]  A. Kadanalı,et al.  Genital flora in pregnancy and its association with group B streptococcal colonization , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[50]  M. Bergeron,et al.  Laboratory detection of group B Streptococcus for prevention of perinatal disease , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[51]  P. Lumbiganon,et al.  The International Infections in Pregnancy Study: group B streptococcal colonization in pregnant women , 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[52]  C E Nord,et al.  Effect of antimicrobial agents on the ecological balance of human microflora. , 2001, The Lancet. Infectious diseases.

[53]  T. Mitsuoka.  Bifidobacteria and their role in human health , 1990, Journal of Industrial Microbiology.

[54]  Emily Malloy,et al.  Laboratory Analysis Techniques for the Perinatal Microbiome: Implications for Studies of Probiotic Interventions , 2021 .

[55]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[56]  S. Schrag,et al.  Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[57]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[58]  M. Singleton.  Group B strep prophylaxis: what are we creating? , 2007, Midwifery today with international midwife.

[59]  Renee Meuse Bishara.  GBS in a homebirth setting. , 2006, Midwifery today with international midwife.

[60]  V. Shah,et al.  Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. , 2004, The Cochrane database of systematic reviews.